A substrate-directed Pd-catalysed o-aroylation strategy has been demonstrated using new aroyl surrogates viz. terminal aryl alkenes and alkynes in the presence of TBHP. By a subtle change in catalyst from Cu to Pd, a differential selectivity is observed. While terminal aryl alkenes/alkynes in the presence of Cu/TBHP are reported to act as o-aryloxy (ArCOO–) sources, the use of Pd/TBHP installs an aroyl (ArCO–) group at the ortho position with respect to the directing arenes.
No takes yet. Share an insight, caveat, or question.
Khatun et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: